Skip to main content
Top

Current Breast Cancer Reports

Issue 2/2015

Content (4 Articles)

Risk, Prevention, and Screening (TA Patel, Section Editor)

Current Multidisciplinary Management of High-Risk Breast Lesions

Therese B. Bevers, Isabelle Bedrosian, Lavinia P. Middleton, Marion E. Scoggins

Risk, Prevention, and Screening (TA Patel, Section Editor)

Vitamin D and Reduction of Breast Cancer Risk

Jennifer K. Lue, Katherine D. Crew

Risk, Prevention, and Screening (TA Patel, Section Editor)

Multiple-Gene Panels and the Future of Genetic Testing

Allison W. Kurian, James M. Ford

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine